VALN

Valneva SE

Healthcare · Biotechnology

$195.42 sample

+3.55 (+1.85%) 1D

Market cap

$850.9B

Price as of

2026-10-15

Latest filing

8-K · 2026-08-17

Alerts

8

Price$195.42 +18.64% 3M daily closessample

197.21163.29

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 05INSInsider buy: Director
Sep 28INSInsider buy: Chief Executive Officer
Sep 17INSInsider buy: General Counsel
Sep 11INSInsider buy: 10% owner
Sep 02INSInsider sell: Director
Aug 26INSInsider sell: EVP, Operations
Aug 17SECForm 144 filed
Aug 06INSInsider sell: 10% owner

Sign up to see the real VALN record →

Company facts

SEC EDGAR registration

Name: Valneva SE
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +16sample, -100 to +100
Reporting currency: USD

Who is positioning in VALN

sample

Insiders: 23 insider transactions over 90 days, net selling, $880.2M
Congress: 2 members traded over 90 days
Institutions · 13F: 39 funds hold $16.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$46.5B +18.4% y/y

Q4 2024Q3 2026

Inventory$28.4B +16.4% y/y

Q4 2024Q3 2026

Accounts receivable$20.8B +8.4% y/y

Q4 2024Q3 2026

Total debt$57.6B +17.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $779.5B +14.0% 3M
Sample peer B: $115.9B -11.0% 3M
Sample peer C: $628.2B +1.3% 3M
Sample peer D: $452.8B -10.3% 3M
Sample peer E: $787.7B +8.5% 3M